Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Respiratory Tract Diseases 1Papillary renal cell carcinoma, sporadic 1Pancreatic Intraductal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Liver Cirrhosis 1Leiomyosarcoma 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Histiocytoma, Malignant Fibrous 1Hereditary leiomyomatosis and renal cell cancer 1

Interventions

tremelimumab 1epigallocatechin gallate 1durvalumab 1babao dan 1Urination 1Standard of Care 1Rosuvastatin Calcium 1Preoperative Exercise 1Furosemide 1Erlotinib Hydrochloride 1Digoxin 1Diagnostic Imaging 1Control Groups 1Cannabidiol 1Breathing Exercises 1Breath Tests 1Blood Specimen Collection 1Aspirin 1Anti-HIV Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Cirrhosis × Erlotinib Hydrochloride × 1 year × Clear all
NCT04172779 2026-05-01

ECHO-B

University of Texas Southwestern Medical Center

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡